首页> 外国专利> HUMAN UROTHELIAL CELL SPECIFIC UROPLAKIN TRANSCRIPTIONAL REGULATORY SEQUENCES, VECTORS COMPRISING UROPLAKIN-SPECIFIC TRANSCRIPTIONAL REGULATORY SEQUENCES, AND METHODS OF USE THEREOF

HUMAN UROTHELIAL CELL SPECIFIC UROPLAKIN TRANSCRIPTIONAL REGULATORY SEQUENCES, VECTORS COMPRISING UROPLAKIN-SPECIFIC TRANSCRIPTIONAL REGULATORY SEQUENCES, AND METHODS OF USE THEREOF

机译:人尿道上皮细胞特异的尿小蛋白转录调控序列,包含尿嘧啶的特异转录调控序列的载体及其使用方法

摘要

The invention provides new urothelial cell specific transcriptional regulatorysequences derived from human uroplakin II hUPII, as well as polynucleotideconstructs such as adenoviral vectors and methods of using hUPII-derived TREs.Additionally, the invention provides adenoviral vectors comprising a gene,preferably an adenovirus gene, under transcriptional control of a urothelialcell-specific transcriptional regulatory element (TRE). These vectors displayurothelial cell-specific cytotoxicity, which is especially useful in thecontext of bladder cancer, in which destruction of these cells is desirable.The invention further provides compositions and host cells comprising thevectors, as well as method of using the adenoviral vectors.
机译:本发明提供了新的尿路上皮细胞特异性转录调控源自人uroplakin II hUPII的序列,以及多核苷酸腺病毒载体等构建体以及使用hUPII衍生的TRE的方法。另外,本发明提供了包含基因的腺病毒载体,在尿路上皮的转录控制下,最好是腺病毒基因细胞特异性转录调节元件(TRE)。这些向量显示尿路上皮细胞特异性细胞毒性,在在膀胱癌的背景下,需要破坏这些细胞。本发明进一步提供了包含该组合物的组合物和宿主细胞。载体,以及使用腺病毒载体的方法。

著录项

  • 公开/公告号CA2404085A1

    专利类型

  • 公开/公告日2001-10-04

    原文格式PDF

  • 申请/专利权人 CELL GENESYS INC.;

    申请/专利号CA20012404085

  • 发明设计人 YU DE-CHAO;ZHANG HONG;HENDERSON DANIEL R.;

    申请日2001-03-21

  • 分类号C12N15/00;C07K14/47;

  • 国家 CA

  • 入库时间 2022-08-22 01:21:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号